FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1387-1397 April 1, 2004 Number 14 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Tall, A. R. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background C-reactive protein is an inflammatory marker believed to be of value in the prediction of coronary events. We report data from a large study of C-reactive protein and other circulating inflammatory markers, as well as updated meta-analyses, to evaluate their relevance to the prediction of coronary heart disease.

Methods Measurements were made in samples obtained at base line from up to 2459 patients who had a nonfatal myocardial infarction or died of coronary heart disease during the study and from up to 3969 controls without a coronary heart disease event in the Reykjavik prospective study of 18,569 participants. Measurements were made in paired samples obtained an average of 12 years apart from 379 of these participants in order to quantify within-person fluctuations in inflammatory marker levels.

Results The long-term stability of C-reactive protein values (within-person correlation coefficient, 0.59; 95 percent confidence interval, 0.52 to 0.66) was similar to that of both blood pressure and total serum cholesterol. After adjustment for base-line values for established risk factors, the odds ratio for coronary heart disease was 1.45 (95 percent confidence interval, 1.25 to 1.68) in a comparison of participants in the top third of the group with respect to base-line C-reactive protein values with those in the bottom third, and similar overall findings were observed in an updated meta-analysis involving a total of 7068 patients with coronary heart disease. By comparison, the odds ratios in the Reykjavik Study for coronary heart disease were somewhat weaker for the erythrocyte sedimentation rate (1.30; 95 percent confidence interval, 1.13 to 1.51) and the von Willebrand factor concentration (1.11; 95 percent confidence interval, 0.97 to 1.27) but generally stronger for established risk factors, such as an increased total cholesterol concentration (2.35; 95 percent confidence interval, 2.03 to 2.74) and cigarette smoking (1.87; 95 percent confidence interval, 1.62 to 2.16).

Conclusions C-reactive protein is a relatively moderate predictor of coronary heart disease. Recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed.

Source Information

From the Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (J.D., J.G.W.); the Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Royal Free Campus, London (G.M.H., M.B.P.); Roche Diagnostics, Tokyo, Japan (S.E.); the Icelandic Heart Association, Kopavogur, Iceland (G.E., V.G.); and the University Department of Medicine, Royal Infirmary, Glasgow, Scotland (A.R., G.D.O.L.).

Address reprint requests to Prof. Danesh at the Department of Public Health and Primary Care, Strangeways Site, Institute of Public Health, University of Cambridge, Cambridge CB1 8RN, United Kingdom.

Full Text of this Article

Related Letters:

C-Reactive Protein and Coronary Heart Disease
Glynn R. J., Cook N. R., Libby P., Willerson J. T., Braunwald E., Foody J. M., Gotto A. M., Wenger N., Ridker P. M., Koenig W., Fuster V., Danesh J., Pepys M., Gudnason V.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:295-298, Jul 15, 2004. Correspondence

This article has been cited by other articles:

• LIANG, K. P., KREMERS, H. M., CROWSON, C. S., SNYDER, M. R., THERNEAU, T. M., ROGER, V. L., GABRIEL, S. E. (2009). Autoantibodies and the Risk of Cardiovascular Events. The Journal of Rheumatology 36: 2462-2469 [Abstract] [Full Text]  
• Sen, S., Lynch, D. R. Jr, Kaltsas, E., Simmons, J., Tan, W. A., Kim, J., Beck, J., Rosamond, W. (2009). Association of Asymptomatic Peripheral Arterial Disease With Vascular Events in Patients With Stroke or Transient Ischemic Attack. Stroke 40: 3472-3477 [Abstract] [Full Text]  
• Crilly, M. A., Kumar, V., Clark, H. J., Scott, N. W., MacDonald, A. G., Williams, D. J. (2009). Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors. Rheumatology (Oxford) 0: kep305v1-kep305 [Abstract] [Full Text]  
• Rana, J S, Cote, M, Despres, J-P, Sandhu, M S, Talmud, P J, Ninio, E, Wareham, N J, Kastelein, J J P, Zwinderman, A H, Khaw, K-T, Boekholdt, S M (2009). Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study. Heart 95: 1682-1687 [Abstract] [Full Text]  
• MacLaine, J. K., Rabie, A. B. M., Wong, R., Blechman, A. (2009). Does orthodontic tooth movement cause an elevation in systemic inflammatory markers?. Eur J Orthod 0: cjp108v1-cjp108 [Abstract] [Full Text]  
• Buckley, D. I., Fu, R., Freeman, M., Rogers, K., Helfand, M. (2009). C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force. ANN INTERN MED 151: 483-495 [Abstract] [Full Text]  
• Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., Humphrey, L. L. (2009). Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force. ANN INTERN MED 151: 496-507 [Abstract] [Full Text]  
• Liu, A, Zhang, W, Tian, X, Zhang, X, Zhang, F, Zeng, X (2009). Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients. Lupus 18: 1112-1118 [Abstract]  
• Conen, D., Rexrode, K. M., Creager, M. A., Ridker, P. M, Pradhan, A. D. (2009). Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women: A Prospective Study. Circulation 120: 1041-1047 [Abstract] [Full Text]  
• Saczynski, J. S., Siggurdsson, S., Jonsson, P. V., Eiriksdottir, G., Olafsdottir, E., Kjartansson, O., Harris, T. B., van Buchem, M. A., Gudnason, V., Launer, L. J. (2009). Glycemic Status and Brain Injury in Older Individuals: The Age Gene/Environment Susceptibility-Reykjavik Study. Diabetes Care 32: 1608-1613 [Abstract] [Full Text]  
• Nozaki, T., Sugiyama, S., Koga, H., Sugamura, K., Ohba, K., Matsuzawa, Y., Sumida, H., Matsui, K., Jinnouchi, H., Ogawa, H. (2009). Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.. J Am Coll Cardiol 54: 601-608 [Abstract] [Full Text]  
• Sierros, V, Fleming, R, Cascioli, M, Brady, T (2009). The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation. Chronic Respiratory Disease 6: 149-155 [Abstract]  
• Sattler, K. J.E., Herrmann, J., Yun, S., Lehmann, N., Wang, Z., Heusch, G., Sack, S., Erbel, R., Levkau, B. (2009). High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention. Eur Heart J 30: 1894-1902 [Abstract] [Full Text]  
• Procopio, C., Andreozzi, F., Laratta, E., Cassese, A., Beguinot, F., Arturi, F., Hribal, M. L., Perticone, F., Sesti, G. (2009). Leptin-Stimulated Endothelial Nitric-Oxide Synthase via an Adenosine 5'-Monophosphate-Activated Protein Kinase/Akt Signaling Pathway Is Attenuated by Interaction with C-Reactive Protein. Endocrinology 150: 3584-3593 [Abstract] [Full Text]  
• Bajwa, E. K., Khan, U. A., Januzzi, J. L., Gong, M. N., Thompson, B. T., Christiani, D. C. (2009). Plasma C-Reactive Protein Levels Are Associated With Improved Outcome in ARDS. Chest 136: 471-480 [Abstract] [Full Text]  
• Almeida, O. P, Norman, P. E, Allcock, R., Bockxmeer, F. v., Hankey, G. J, Jamrozik, K., Flicker, L. (2009). Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: The Health in Men Study. Int J Epidemiol 38: 1049-1059 [Abstract] [Full Text]  
• Lind, M., Boman, K., Johansson, L., Nilsson, T. K., Ohlin, A.-K., Birgander, L. S., Jansson, J.-H. (2009). Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment. Arch Intern Med 169: 1210-1215 [Abstract] [Full Text]  
• Elliott, P., Chambers, J. C., Zhang, W., Clarke, R., Hopewell, J. C., Peden, J. F., Erdmann, J., Braund, P., Engert, J. C., Bennett, D., Coin, L., Ashby, D., Tzoulaki, I., Brown, I. J., Mt-Isa, S., McCarthy, M. I., Peltonen, L., Freimer, N. B., Farrall, M., Ruokonen, A., Hamsten, A., Lim, N., Froguel, P., Waterworth, D. M., Vollenweider, P., Waeber, G., Jarvelin, M.-R., Mooser, V., Scott, J., Hall, A. S., Schunkert, H., Anand, S. S., Collins, R., Samani, N. J., Watkins, H., Kooner, J. S. (2009). Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease. JAMA 302: 37-48 [Abstract] [Full Text]  
• Agarwal, S. (2009). The Association of Active and Passive Smoking With Peripheral Arterial Disease: Results From NHANES 1999-2004. ANGIOLOGY 60: 335-345 [Abstract]  
• Semb, A. G., Ueland, T., Aukrust, P., Wareham, N. J., Luben, R., Gullestad, L., Kastelein, J. J.P., Khaw, K.-T., Boekholdt, S. M. (2009). Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-{kappa}B Ligand and Risk for Coronary Events: A Nested Case-Control Approach in the Prospective EPIC-Norfolk Population Study 1993-2003. Arterioscler. Thromb. Vasc. Bio. 29: 975-980 [Abstract] [Full Text]  
• Ridker, P. M (2009). The JUPITER Trial: Results, Controversies, and Implications for Prevention. Circ Cardiovasc Qual Outcomes 2: 279-285 [Full Text]  
• Elovainio, M., Aalto, A.-M., Kivimaki, M., Pirkola, S., Sundvall, J., Lonnqvist, J., Reunanen, A. (2009). Depression and C-Reactive Protein: Population-Based Health 2000 Study. Psychosom. Med. 71: 423-430 [Abstract] [Full Text]  
• Woodward, M., Welsh, P., Rumley, A., Tunstall-Pedoe, H., Lowe, G. D.O. (2009). Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10 year cohort study in Glasgow, Scotland. Eur Heart J 0: ehp115v1-ehp115 [Abstract] [Full Text]  
• Fujita, M., Ueno, K., Hata, A. (2009). Lower Frequency of Daily Teeth Brushing Is Related to High Prevalence of Cardiovascular Risk Factors. Exp. Biol. Med. 234: 387-394 [Abstract] [Full Text]  
• Lui, M. M.-s., Lam, J. C.-m., Mak, H. K.-F., Xu, A., Ooi, C., Lam, D. C.-l., Mak, J. C.-w., Khong, P. L., Ip, M. S.-M. (2009). C-Reactive Protein Is Associated With Obstructive Sleep Apnea Independent of Visceral Obesity. Chest 135: 950-956 [Abstract] [Full Text]  
• Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffele, M. G., Donker, A. J. M., Stehouwer, C. D. A. (2009). Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus. Arch Intern Med 169: 616-625 [Abstract] [Full Text]  
• Chida, Y., Steptoe, A. (2009). The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence.. J Am Coll Cardiol 53: 936-946 [Abstract] [Full Text]  
• Denollet, J., Pedersen, S. S. (2009). Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk.. J Am Coll Cardiol 53: 947-949 [Full Text]  
• Saczynski, J. S., Sigurdsson, S., Jonsdottir, M. K., Eiriksdottir, G., Jonsson, P. V., Garcia, M. E., Kjartansson, O., Lopez, O., van Buchem, M. A., Gudnason, V., Launer, L. J. (2009). Cerebral Infarcts and Cognitive Performance: Importance of Location and Number of Infarcts. Stroke 40: 677-682 [Abstract] [Full Text]  
• Kelley, D. S., Siegel, D., Fedor, D. M., Adkins, Y., Mackey, B. E. (2009). DHA Supplementation Decreases Serum C-Reactive Protein and Other Markers of Inflammation in Hypertriglyceridemic Men. J. Nutr. 139: 495-501 [Abstract] [Full Text]  
• Bo, M., Corsinovi, L., Brescianini, A., Sona, A., Astengo, M., Dumitrache, R., Ferrio, M. F., Pricop, L., Fonte, G. (2009). High-Sensitivity C-Reactive Protein Is Not Independently Associated With Peripheral Subclinical Atherosclerosis. ANGIOLOGY 60: 12-20 [Abstract]  
• Polotsky, V. Y., Patil, S. P., Savransky, V., Laffan, A., Fonti, S., Frame, L. A., Steele, K. E., Schweizter, M. A., Clark, J. M., Torbenson, M. S., Schwartz, A. R. (2009). Obstructive Sleep Apnea, Insulin Resistance, and Steatohepatitis in Severe Obesity. Am. J. Respir. Crit. Care Med. 179: 228-234 [Abstract] [Full Text]  
• Shah, T., Casas, J. P, Cooper, J. A, Tzoulaki, I., Sofat, R., McCormack, V., Smeeth, L., Deanfield, J. E, Lowe, G. D, Rumley, A., Fowkes, F G. R, Humphries, S. E, Hingorani, A. D (2009). Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol 38: 217-231 [Abstract] [Full Text]  
• Stott, D. J, Welsh, P., Rumley, A., Robertson, M., Ford, I., Sattar, N., Westendorp, R. G J, Jukema, J W., Cobbe, S. M, Lowe, G. D O (2009). Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 38: 253-261 [Abstract] [Full Text]  
• Mora, S., Musunuru, K., Blumenthal, R. S. (2009). The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines. Clin. Chem. 55: 219-228 [Abstract] [Full Text]  
• Glynn, R. J., MacFadyen, J. G., Ridker, P. M (2009). Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study. Clin. Chem. 55: 305-312 [Abstract] [Full Text]  
• Ridker, P. M (2009). C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease. Clin. Chem. 55: 209-215 [Full Text]  
• Hingorani, A. D., Shah, T., Casas, J. P., Humphries, S. E., Talmud, P. J. (2009). C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?. Clin. Chem. 55: 239-255 [Abstract] [Full Text]  
• Schumacher, W., Cockcroft, J., Timpson, N. J., McEniery, C. M., Gallacher, J., Rumley, A., Lowe, G., Smith, G. D., Wilkinson, I. B., Ben-Shlomo, Y. (2009). Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity. Hypertension 53: 150-157 [Abstract] [Full Text]  
• de Ruijter, W., Westendorp, R. G J, Assendelft, W. J J, den Elzen, W. P J, de Craen, A. J M, le Cessie, S., Gussekloo, J. (2009). Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338: a3083-a3083 [Abstract] [Full Text]  
• Grammer, T. B., Marz, W., Renner, W., Bohm, B. O., Hoffmann, M. M. (2009). C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study. Eur Heart J 30: 170-182 [Abstract] [Full Text]  
• SHISHEHBOR, M. H., HAZEN, S. L. (2009). JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?. Cleveland Clinic Journal of Medicine 76: 37-44 [Abstract] [Full Text]  
• Sathiyapriya, V., Nandeesha, H., Selvaraj, N., Bobby, Z., Agrawal, A., Pavithran, P. (2009). Association Between Protein-Bound Sialic Acid and High-Sensitivity C-Reactive Protein in Essential Hypertension: A Possible Indication of Underlying Cardiovascular Risk. ANGIOLOGY 59: 721-726 [Abstract]  
• Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F. (2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Saczynski, J. S., Jonsdottir, M. K., Garcia, M. E., Jonsson, P. V., Peila, R., Eiriksdottir, G., Olafsdottir, E., Harris, T. B., Gudnason, V., Launer, L. J. (2008). Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study. Am J Epidemiol 168: 1132-1139 [Abstract] [Full Text]  
• Zacho, J., Tybjaerg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., Nordestgaard, B. G. (2008). Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease. NEJM 359: 1897-1908 [Abstract] [Full Text]  
• Schunkert, H., Samani, N. J. (2008). Elevated C-Reactive Protein in Atherosclerosis -- Chicken or Egg?. NEJM 359: 1953-1955 [Full Text]  
• Rosenzweig, J. L., Ferrannini, E., Grundy, S. M., Haffner, S. M., Heine, R. J., Horton, E. S., Kawamori, R. (2008). Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93: 3671-3689 [Abstract] [Full Text]  
• Welsh, P., Whincup, P.H., Papacosta, O., Wannamethee, S.G., Lennon, L., Thomson, A., Rumley, A., Lowe, G.D.O. (2008). Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men. QJM 101: 785-791 [Abstract] [Full Text]  
• Surtees, P. G., Wainwright, N. W. J., Boekholdt, S. M., Luben, R. N., Wareham, N. J., Khaw, K.-T. (2008). Major Depression, C-Reactive Protein, and Incident Ischemic Heart Disease in Healthy Men and Women. Psychosom. Med. 70: 850-855 [Abstract] [Full Text]  
• Barcelo-Coblijn, G., Murphy, E. J, Othman, R., Moghadasian, M. H, Kashour, T., Friel, J. K (2008). Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am. J. Clin. Nutr. 88: 801-809 [Abstract] [Full Text]  
• Maingrette, F., Li, L., Renier, G. (2008). C-reactive protein enhances macrophage lipoprotein lipase expression. J. Lipid Res. 49: 1926-1935 [Abstract] [Full Text]  
• Escobar-Morreale, H. F, Botella-Carretero, J. I, Martinez-Garcia, M. A., Luque-Ramirez, M., Alvarez-Blasco, F., Millan, J. L S. (2008). Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome. Eur J Endocrinol 159: 225-232 [Abstract] [Full Text]  
• Bonaca, M. P., Morrow, D. A. (2008). Defining a Role for Novel Biomarkers in Acute Coronary Syndromes. Clin. Chem. 54: 1424-1431 [Abstract] [Full Text]  
• Ho, K. J., Owens, C. D., Longo, T., Sui, X. X., Ifantides, C., Conte, M. S. (2008). C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-{beta}. Am. J. Physiol. Heart Circ. Physiol. 295: H1132-H1140 [Abstract] [Full Text]  
• Agewall, S. (2008). Acute and stable coronary heart disease: different risk factors. Eur Heart J 29: 1927-1929 [Full Text]  
• Saczynski, J. S., Jonsdottir, M. K., Sigurdsson, S., Eiriksdottir, G., Jonsson, P. V., Garcia, M. E., Kjartansson, O., van Buchem, M. A., Gudnason, V., Launer, L. J. (2008). White Matter Lesions and Cognitive Performance: The Role of Cognitively Complex Leisure Activity. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63: 848-854 [Abstract] [Full Text]  
• Genoud, M., Wietlisbach, V., Feihl, F., Mermod, A., Morin, D., Darioli, R., Nicod, P., Mooser, V., Waeber, B., Hayoz, D., Waeber, G. (2008). Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS Project. ANGIOLOGY 59: 484-492 [Abstract]  
• Hogh, A. L., Joensen, J., Lindholt, J. S., Jacobsen, M. R., Ostergaard, L. (2008). C-Reactive Protein Predicts Future Arterial and Cardiovascular Events in Patients With Symptomatic Peripheral Arterial Disease. VASC ENDOVASCULAR SURG 42: 341-347 [Abstract]  
• Mauger, J.-F., Levesque, J., Paradis, M.-E., Bergeron, N., Tchernof, A., Couture, P., Lamarche, B. (2008). Intravascular Kinetics of C-Reactive Protein and Their Relationships with Features of the Metabolic Syndrome. J. Clin. Endocrinol. Metab. 93: 3158-3164 [Abstract] [Full Text]  
• Rodriguez-Moran, M, Guerrero-Romero, F (2008). Serum magnesium and C-reactive protein levels. Arch. Dis. Child. 93: 676-680 [Abstract] [Full Text]  
• Fujita, T. (2008). Association between Protein Levels and Mortality in Patients with Peripheral Arterial Disease. ANN INTERN MED 149: 64-64 [Full Text]  
• Arima, H., Kubo, M., Yonemoto, K., Doi, Y., Ninomiya, T., Tanizaki, Y., Hata, J., Matsumura, K., Iida, M., Kiyohara, Y. (2008). High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese: The Hisayama Study. Arterioscler. Thromb. Vasc. Bio. 28: 1385-1391 [Abstract] [Full Text]  
• Povsic, T. J., Goldschmidt-Clermont, P. J. (2008). Review: Endothelial progenitor cells: markers of vascular reparative capacity. Ther Adv Cardiovasc Dis 2: 199-213 [Abstract]  
• Baum, M K, Rafie, C, Sales, S, Lai, S, Duan, R, Jayaweera, D T, Page, J B, Campa, A (2008). C-reactive protein: a poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases. Int J STD AIDS 19: 410-413 [Abstract] [Full Text]  
• Kelley-Hedgepeth, A., Lloyd-Jones, D. M., Colvin, A., Matthews, K. A., Johnston, J., Sowers, M. R., Sternfeld, B., Pasternak, R. C., Chae, C. U., for the SWAN Investigators, (2008). Ethnic Differences in C-Reactive Protein Concentrations. Clin. Chem. 54: 1027-1037 [Abstract] [Full Text]  
• Tabassum, F., Kumari, M., Rumley, A., Lowe, G., Power, C., Strachan, D. P. (2008). Effects of Socioeconomic Position on Inflammatory and Hemostatic Markers: A Life-Course Analysis in the 1958 British Birth Cohort. Am J Epidemiol 167: 1332-1341 [Abstract] [Full Text]  
• von Eynatten, M., Hamann, A., Twardella, D., Nawroth, P. P., Brenner, H., Rothenbacher, D. (2008). Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J 29: 1307-1315 [Abstract] [Full Text]  
• Levinson, S. S. (2008). New cardiovascular risk determinants do exist and are clinically useful. Eur Heart J 29: 1335-1335 [Full Text]  
• Debing, E., Peeters, E., Demanet, C., De Waele, M., Van den Brande, P. (2008). Markers of Inflammation in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis: A Case-Control Study. VASC ENDOVASCULAR SURG 42: 122-127 [Abstract]  
• Thomas, N-E, Baker, J S, Graham, M R, Cooper, S-M, Davies, B (2008). C-reactive protein in schoolchildren and its relation to adiposity, physical activity, aerobic fitness and habitual diet. Br. J. Sports. Med. 42: 357-360 [Abstract] [Full Text]  
• Anuurad, E., Rubin, J., Chiem, A., Tracy, R. P., Pearson, T. A., Berglund, L. (2008). High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans. J. Clin. Endocrinol. Metab. 93: 1482-1488 [Abstract] [Full Text]  
• Gimeno, D, Ferrie, J E, Elovainio, M, Pulkki-Raback, L, Keltikangas-Jarvinen, L, Eklund, C, Hurme, M, Lehtimaki, T, Marniemi, J, Viikari, J S A, Raitakari, O T, Kivimaki, M (2008). When do social inequalities in C-reactive protein start? A life course perspective from conception to adulthood in the Cardiovascular Risk in Young Finns Study. Int J Epidemiol 37: 290-298 [Abstract] [Full Text]  
• Nation, D. A., Gonzales, J. A., Mendez, A. J., Zaias, J., Szeto, A., Brooks, L. G., Paredes, J., D'Angola, A., Schneiderman, N., McCabe, P. M. (2008). The Effect of Social Environment on Markers of Vascular Oxidative Stress and Inflammation in the Watanabe Heritable Hyperlipidemic Rabbit. Psychosom. Med. 70: 269-275 [Abstract] [Full Text]  
• Bennet, A., Di Angelantonio, E., Erqou, S., Eiriksdottir, G., Sigurdsson, G., Woodward, M., Rumley, A., Lowe, G. D. O., Danesh, J., Gudnason, V. (2008). Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data. Arch Intern Med 168: 598-608 [Abstract] [Full Text]  
• Spiel, A. O., Gilbert, J. C., Jilma, B. (2008). Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes. Circulation 117: 1449-1459 [Abstract] [Full Text]  
• Clarke, R., Emberson, J. R., Breeze, E., Casas, J. P., Parish, S., Hingorani, A. D., Fletcher, A., Collins, R., Smeeth, L. (2008). Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 29: 800-809 [Abstract] [Full Text]  
• Conen, D, Everett, B M, Glynn, R J, Ridker, P M (2008). Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart 94: e13-e13 [Abstract] [Full Text]  
• Dandona, P. (2008). Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein. Mayo Clin Proc. 83: 333-342 [Abstract] [Full Text]  
• Smulders, Y. M., Thijs, A., Twisk, J. W. (2008). New cardiovascular risk determinants do exist and are clinically useful. Eur Heart J 29: 436-440 [Abstract] [Full Text]  
• Lee, S-S., Singh, S., Magder, L., Petri, M. (2008). Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 17: 114-123 [Abstract]  
• McGuire, D. K., Inzucchi, S. E. (2008). New Drugs for the Treatment of Diabetes Mellitus: Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications. Circulation 117: 440-449 [Full Text]  
• Brevetti, G., Schiano, V., Laurenzano, E., Giugliano, G., Petretta, M., Scopacasa, F., Chiariello, M. (2008). Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J 29: 224-230 [Abstract] [Full Text]  
• Packard, R. R. S., Libby, P. (2008). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin. Chem. 54: 24-38 [Abstract] [Full Text]  
• Williams, E. S., Shah, S. J., Ali, S., Na, B. Y., Schiller, N. B., Whooley, M. A. (2008). C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail 10: 63-69 [Abstract] [Full Text]  
• Stern, S. (2008). Are We Getting Nearer to Screening for Atherosclerosis?. Circulation 117: 122-126 [Full Text]